Skip to main content
. 2010 Aug 5;12(2):219–226. doi: 10.1007/s10194-010-0243-y

Fig. 4.

Fig. 4

Frequency (%) of occurrence of nausea, vomiting, photophobia, phonophobia, and osmophobia 2, 4, 24, and 48 h after administration of frovatriptan (open bars) or rizatriptan (striped bars) in the 125 patients of the intention-to-treat population